Mayo Clinic Researchers Test Novel Injection of Gene Therapy Vectors Directly Into the Kidney
January 01, 2020
January 01, 2020
NEW ROCHELLE, New York, Jan. 1 -- Mary Ann Liebert Inc. issued the following news release:
Before gene therapy can be used to treat renal diseases, delivery of therapeutic genes to the kidney must become much more efficient. A novel approach in which three different gene delivery vectors were injected intravenously and directly into the kidneys of mice was reported in an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click h . . .
Before gene therapy can be used to treat renal diseases, delivery of therapeutic genes to the kidney must become much more efficient. A novel approach in which three different gene delivery vectors were injected intravenously and directly into the kidneys of mice was reported in an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click h . . .